Large and Multi-Nuclei Blasts in Acute Myeloid Leukemia with the Hypotriploid Karyotype and TP53 Mutation with P210 BCR::ABL1 Transcript.

Detalles Bibliográficos
Publicado en:Turkish Journal of Hematology Vol. 42; no. 2; pp. 146 - 148
Autores principales: Yihong Huangchuan, Xueyan Chen
Formato: case study letter pictorial tables/charts Journal Article
Publicado: Galenos Yayinevi Tic. LTD. STI 2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=185337757&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 185337757
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        13007777
        1D5T
      jtl: Turkish Journal of Hematology
      issn: 13007777
      maglogo: N
    pubinfo:
      dt: 2025
      vid: 42
      iid: 2
      pid: 28155
      pub: Galenos Yayinevi Tic. LTD. STI
    artinfo:
      ui:
        185337757
        185337757
        185337757
        10.4274/tjh.galenos.2025.2025.0428
        185337757
      ppf: 146
      ppct: 2
      formats:
      tig:
        atl: Large and Multi-Nuclei Blasts in Acute Myeloid Leukemia with the Hypotriploid Karyotype and TP53 Mutation with P210 BCR::ABL1 Transcript.
      aug:
        au:
          Yihong Huangchuan
          Xueyan Chen
        affil: Shenzhen Longhua District People's Hospital, Department of Clinical Laboratory, Shenzhen, P.R. China
      sug:
        subj:
          Leukemia, Myeloid, Acute Diagnosis
          Chromosome Aberrations Diagnosis
          Leukemia, Myeloid, Acute Drug Therapy
          Chromosome Aberrations Drug Therapy
          Mutation
          Treatment Outcomes
          Female
          Middle Age
          Fatigue Etiology
          Hematologic Tests
          Bone Marrow Examination
          Antineoplastic Agents Administration and Dosage
          Tyrosine Kinase Inhibitors Administration and Dosage
          Antineoplastic Agents, Combined Administration and Dosage
          Leukemia, Myeloid, Acute Familial and Genetic
          Chromosome Aberrations Familial and Genetic
          Middle Aged: 45-64 years
          Female
      pubtype: Academic Journal
      doctype:
        case study
        letter
        pictorial
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N